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We evaluated measurement of urinary 4-hydroxyphenylacetic acid as a potential screening method for smallbowel disease and bacterial overgrowth syndromes in 360 unselected acutely ill infants and children. Control data were obtained on 120 healthy children, ages 1.5 to 15 years, from a general medical practice, 48 healthy infants, ages one to five years, from local day nurseries, and 150 healthy babies, ages less than one to eight days. Comparative data were from 300 acutely ill hospitalized babies and children, ranging in age from less than one day to 15 years and without clinical evidence for small-bowel disease and bacterial overgrowth syndrome. No false-negative results and only 2% false-positive results were observed.
Among the 10 patients whose urinary excretion of the analyte was considered to be abnormal were patients with Giardia lamb/ia infestation, ileal resection with blind loop, and other diseases of the small intestine associated with bacterial overgrowth. We conclude that measurement of 4 
Patients and Materials
We studied children and infants who presented during an approximately three-year period with diarrhea, vomiting, failure to thrive, convulsions, coma, or metabolic acidosis, and who were referred for screening for possible underlying met-abolic diseases (6) from the pediatric department and special-care baby unit at Northwick Park and other hospitals.
The total number of patients studied was 360; they ranged in age from one day to 12 years.
Control data were derived from 120 normal children in the age range 1. 
Results
Histogram plots of the control data showed the data to be skewed and these were re-plotted on log scales [after Chalmers et al. (7) values, all on the upper end of the distribution. The lower limit of the normal data in Group A is on the limit of detectability, and therefore the normal limit has also been calculated so as to exclude 5% of the observed values, all on the high side of the distribution.
The normal data obtained are given in 
Discussion
Increased urinary excretion of 4-hydroxyphenylacetic acid by about half of patients with cystic fibrosis has been reported by several groups (1) (2) (3) (4) , and its occurrence has been ascribed to degradation of amino acids derived from hydrolyzed dietary protein by intestinal bacteria that contain L-amino acid decarboxylases.
Tyrosine is degraded to tyramine in the process, p-tyramine in man being almost exclusively of bacterial origin (11) , and the tyramine is subsequently deaminated and oxidized to 4-hydroxyphenylacetic acid, which is excreted unchanged and unconjugated in the urine. The bacterial origin of both p-tyramine and of 4-hydroxyphenylacetic acid has been further confirmed by their diminished excretion by patients treated with neomycin (3) and by germ-free rats as compared to normal rats (12) . Van der Heiden et al. (5) , in studies on total aromatic acids excretion by patients with known intestinal disease, found that 4-hydroxyphenylacetic acid offered the best discriminatory index of intestinal bacterial activity and overgrowth when compared to other aromatic acids.
In the present work, five of 11 patients with cystic fibrosis excreted abnormal amounts of 4-hydroxyphenylacetic acid in their urine, in confirmation of previous studies. However, all five patients were severely affected by the disease or had evidence of other small-bowel disease, for example diarrhea (Table 3) . Clinical diagnoses had not been confirmed on the 360 acutely ill children and infants included in the study at the time of urine analysis and the patients were generally unselected.
The (15, 16) and is the likely cause of the abnormal organic aciduria. Measurement of urinary 4-hydroxyphenylacetic acid is therefore useful in assessing whether or not a blind ioop exists, and may be better discriminator than phenol, p-cresol, or indican (17) . Bacterial proliferation also may be assumed in most of the other patients in whom increased excretion of 4-hydroxyphenylacetic acid has been observed, for example, the patients with septicemia and bacterial colonization at birth and with congenital aplastic anemia in whom low immunoglobulin concentrations were observed. We have also observed increased excretion of 4-hydroxyphenylacetic Children with these deficiencies are also frequently infested with Giardia (13, 14) .
The absence of false-negative values and the occurrence of relatively few false-positive results in a large series of patients illustrates the potential value of measuring urinary 4-hydroxyphenylacetic acid as a screening test for small-bowel disease and bacterial overgrowth syndromes. Its measurement in urine is specific and relatively simple by gas chromatography, and many samples may be processed daily. The acid is excreted in unconjugated form and only an untimed urine specimen is required. It should be possible to develop a more rapid, simple, but specific method for the assay, suitable for mechanized techniques.
